Acid reflux disease may increase risk of cancers of the larynx and esophagus Hina Zahid24 Feb 2021 6:15 AM ISTResults from a large U.S. government prospective study indicate that gastroesophageal reflux disease (GERD), which also causes heartburn symptoms, is...
Preoperative nutritional index may predict postoperative outcome in elderly with CRC MD Bureau20 Feb 2021 8:30 AM ISTOnodera's prognostic nutritional index (PNI) indicates the patient's nutritional and immunological status and is used to predict the risk of several...
Chemotherapy Induced Hearing Loss can be Prevented, claims study MD Bureau19 Feb 2021 8:45 PM ISTHearing loss as a potential side effect of chemotherapy is more likely with chemotherapies that fall into the category of platinum-based drugs, such...
Perioperative care may reduce death after surgery in Low middle income countries MD Bureau18 Feb 2021 7:00 PM ISTCancer prevalence and its associated mortality are increasing in low-income and middle-income countries (LMICs). In a recent study, researchers have...
Cabozantinib most effective treatment for metastatic papillary kidney cancer Hina Zahid18 Feb 2021 7:45 AM ISTA SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in...
Short, noncontrast MRI, a potential screening tool for prostate cancer MD Bureau17 Feb 2021 10:07 PM ISTIn prostate cancer, various imaging modalities are available, but the evidence is limited to use in men within secondary care rather than the general...
Nivolumab effective treatment for malignant mesothelioma Hina Zahid16 Feb 2021 6:44 PM ISTSingapore - Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at...
New class of drug leads to 30% reduced risk of death for bladder cancer patients Hina Zahid15 Feb 2021 10:41 AM ISTA new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most...
FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy Hina Zahid15 Feb 2021 3:30 AM ISTSILVER SPRING - Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency...
Reduced-dose RT with Cisplatin improves outcomes for HPV-associated oropharyngeal carcinoma Hina Zahid12 Feb 2021 10:30 PM ISTA combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for...
Melatonin increases overall survival of prostate cancer patients, finds study Hina Zahid12 Feb 2021 8:40 PM ISTOncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation...
PET Imaging Can Predict Responders of Hormone therapy in Breast Cancer Patients MD Bureau11 Feb 2021 7:30 PM ISTEstrogen-receptor-positivity (ER+)has significant prognostic value and is the main predictor of sensitivity to endocrine therapy (ET). However, up to...
